Results 21 to 30 of about 210,319 (212)

Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs. [PDF]

open access: yes, 2013
Objectives To estimate the cost-effectiveness of remote monitoring strategies versus usual care for adults recently discharged after a heart failure (HF) exacerbation.
Al-Mohammad, A   +11 more
core   +1 more source

Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China

open access: yesFrontiers in Pharmacology, 2019
PurposeAgents that inhibit sodium glucose co-transporter 2 (SGLT2), including canagliflozin and dapagliflozin, become available for the treatment of Chinese patients with type 2 diabetes mellitus (T2DM).
Xingyun Hou, Xu Wan, Bin Wu
doaj   +1 more source

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis. [PDF]

open access: yes, 2014
BackgroundCurrent treatment of diffuse-large-B-cell lymphoma (DLBCL) includes rituximab, an expensive drug, combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy.
Beca, Jaclyn   +15 more
core   +2 more sources

The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [PDF]

open access: yes, 2017
Background: Immune checkpoint inhibitors improve outcomes compared with chemotherapy in lung cancer. Tumor PD-L1 receptor expression is being studied as a predictive biomarker. The objective of this study was to assess the cost-effectiveness and economic
Abdel-Rahman   +25 more
core   +3 more sources

Delivering diabetes education through nurseled telecoaching : cost-effectiveness analysis [PDF]

open access: yes, 2016
Background : People with diabetes have a high risk of developing micro-and macrovascular complications associated with diminished life expectancy and elevated treatment costs. Patient education programs can improve diabetes control in the short term, but
Aertgeerts, Bert   +5 more
core   +3 more sources

The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi [PDF]

open access: yes, 2009
The incremental cost effectiveness of an integrated care package (i.e., medical care including antiretroviral therapy (ART) and other services such as psychological and social support) for people living with HIV/AIDS was calculated in a not-for-profit ...
Basenya, O   +4 more
core   +3 more sources

Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial [PDF]

open access: yes, 2003
OBJECTIVE: To evaluate the cost effectiveness of standard treatment with and without the addition of ward based non-invasive ventilation in patients admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease.
Elliott, M.W.   +3 more
core   +2 more sources

Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold

open access: yesClinicoEconomics and Outcomes Research, 2015
In health technology assessment (HTA) agencies where cost-effectiveness plays a role in decision-making, an incremental cost-effectiveness ratio (ICER) threshold is often used to inform reimbursement decisions. The acceptance of submissions with ICERs higher than the threshold was assessed across different agencies and across indications, in order to ...
Griffiths, Elizabeth   +3 more
openaire   +6 more sources

Applying the net-benefit framework for assessing cost-effectiveness of interventions towards universal health coverage

open access: yesCost Effectiveness and Resource Allocation, 2012
In assessing the cost-effectiveness of an intervention, the interpretation and handling of uncertainties of the traditional summary measure, the Incremental Cost Effectiveness Ratio (ICER), can be problematic.
Hounton Sennen, Newlands David
doaj   +1 more source

Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective

open access: yesDermatology and Therapy, 2023
Introduction This study assessed the cost-effectiveness of secukinumab compared with other biologics (adalimumab, infliximab, ustekinumab, ixekizumab, guselkumab, and Yisaipu [etanercept biosimilar]) for moderate-to-severe plaque psoriasis from the ...
Jinsui Zhang   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy